Worldwide spending on cancer medications hit $100 billion last year; Bayer adds an anticoagulant to its pipeline for $100 million; GlaxoSmithKline has a new chairman
Walgreen Co. sues Endo over pay-for-delay
April 2, 2015
3:30 pm
Walgreen alleges Endo conspired to keep generic Opana ER off the market.
FDA finalizes opioid guidance
April 1, 2015
6:43 pm
Opioids lacking abuse-foiling technology will remain available.
Opioid deterrence may work, labeling rules are coming
NIH project for genome sequencing of newborns commences; remote care, next-gen. DNA sequencing top list of 2014 healthcare-market trends; WHO plans evaluation of contagious-disease response.
Rx-opioid related deaths fall for the first time in 13 years
The Center for Drug Evaluation and Research’s director says there is a need for new opioids and cuts off dosing comparisons between extended-release and immediate-release opioids.